172 related articles for article (PubMed ID: 21371853)
1. A population-based validation of the prognostic model PREDICT for early breast cancer.
Wishart GC; Bajdik CD; Azzato EM; Dicks E; Greenberg DC; Rashbass J; Caldas C; Pharoah PD
Eur J Surg Oncol; 2011 May; 37(5):411-7. PubMed ID: 21371853
[TBL] [Abstract][Full Text] [Related]
2. The prognosis of invasive ductal carcinoma, lobular carcinoma and mixed ductal and lobular carcinoma according to molecular subtypes of the breast.
Zhao H
Breast Cancer; 2021 Jan; 28(1):187-195. PubMed ID: 32812198
[TBL] [Abstract][Full Text] [Related]
3. Population-based validation of the prognostic model ADJUVANT! for early breast cancer.
Olivotto IA; Bajdik CD; Ravdin PM; Speers CH; Coldman AJ; Norris BD; Davis GJ; Chia SK; Gelmon KA
J Clin Oncol; 2005 Apr; 23(12):2716-25. PubMed ID: 15837986
[TBL] [Abstract][Full Text] [Related]
4. PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2.
Wishart GC; Bajdik CD; Dicks E; Provenzano E; Schmidt MK; Sherman M; Greenberg DC; Green AR; Gelmon KA; Kosma VM; Olson JE; Beckmann MW; Winqvist R; Cross SS; Severi G; Huntsman D; Pylkäs K; Ellis I; Nielsen TO; Giles G; Blomqvist C; Fasching PA; Couch FJ; Rakha E; Foulkes WD; Blows FM; Bégin LR; van't Veer LJ; Southey M; Nevanlinna H; Mannermaa A; Cox A; Cheang M; Baglietto L; Caldas C; Garcia-Closas M; Pharoah PD
Br J Cancer; 2012 Aug; 107(5):800-7. PubMed ID: 22850554
[TBL] [Abstract][Full Text] [Related]
5. Nomograms predict survival of patients with lymph node-positive, luminal a breast cancer.
Li Y; Ma L
BMC Cancer; 2021 Aug; 21(1):965. PubMed ID: 34454451
[TBL] [Abstract][Full Text] [Related]
6. Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study.
Mook S; Schmidt MK; Rutgers EJ; van de Velde AO; Visser O; Rutgers SM; Armstrong N; van't Veer LJ; Ravdin PM
Lancet Oncol; 2009 Nov; 10(11):1070-6. PubMed ID: 19801202
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant endocrine therapy in pre- versus postmenopausal patients with steroid hormone receptor-positive breast cancer: results from a large population-based cohort of a cancer registry.
Inwald EC; Koller M; Klinkhammer-Schalke M; Zeman F; Hofstädter F; Lindberg P; Gerstenhauer M; Schüler S; Treeck O; Ortmann O
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2229-40. PubMed ID: 26253629
[TBL] [Abstract][Full Text] [Related]
8. Breast screening and breast cancer survival in Aboriginal and Torres Strait Islander women of Australia.
Roder D; Webster F; Zorbas H; Sinclair S
Asian Pac J Cancer Prev; 2012; 13(1):147-55. PubMed ID: 22502658
[TBL] [Abstract][Full Text] [Related]
9. PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer.
Wishart GC; Azzato EM; Greenberg DC; Rashbass J; Kearins O; Lawrence G; Caldas C; Pharoah PD
Breast Cancer Res; 2010; 12(1):R1. PubMed ID: 20053270
[TBL] [Abstract][Full Text] [Related]
10. An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom.
Campbell HE; Taylor MA; Harris AL; Gray AM
Br J Cancer; 2009 Oct; 101(7):1074-84. PubMed ID: 19724274
[TBL] [Abstract][Full Text] [Related]
11. Validation of the online prediction tool PREDICT v. 2.0 in the Dutch breast cancer population.
van Maaren MC; van Steenbeek CD; Pharoah PDP; Witteveen A; Sonke GS; Strobbe LJA; Poortmans PMP; Siesling S
Eur J Cancer; 2017 Nov; 86():364-372. PubMed ID: 29100191
[TBL] [Abstract][Full Text] [Related]
12. Accuracy validation of adjuvant! online in Taiwanese breast cancer patients--a 10-year analysis.
Yao-Lung K; Dar-Ren C; Tsai-Wang C
BMC Med Inform Decis Mak; 2012 Sep; 12():108. PubMed ID: 22985190
[TBL] [Abstract][Full Text] [Related]
13. Validation of the online prediction model CancerMath in the Dutch breast cancer population.
Hoveling LA; van Maaren MC; Hueting T; Strobbe LJA; Hendriks MP; Sonke GS; Siesling S
Breast Cancer Res Treat; 2019 Dec; 178(3):665-681. PubMed ID: 31471837
[TBL] [Abstract][Full Text] [Related]
14. Mixed Invasive Ductal and Lobular Carcinoma of the Breast: Prognosis and the Importance of Histologic Grade.
Metzger-Filho O; Ferreira AR; Jeselsohn R; Barry WT; Dillon DA; Brock JE; Vaz-Luis I; Hughes ME; Winer EP; Lin NU
Oncologist; 2019 Jul; 24(7):e441-e449. PubMed ID: 30518616
[TBL] [Abstract][Full Text] [Related]
15. Modified lymph node ratio improves the prognostic predictive ability for breast cancer patients compared with other lymph node staging systems.
Jin ML; Gong Y; Pei YC; Ji P; Hu X; Shao ZM
Breast; 2020 Feb; 49():93-100. PubMed ID: 31783315
[TBL] [Abstract][Full Text] [Related]
16. Relative effectiveness of adjuvant chemotherapy for invasive lobular compared with invasive ductal carcinoma of the breast.
Marmor S; Hui JYC; Huang JL; Kizy S; Beckwith H; Blaes AH; Rueth NM; Tuttle TM
Cancer; 2017 Aug; 123(16):3015-3021. PubMed ID: 28382636
[TBL] [Abstract][Full Text] [Related]
17. Validation of the PREDICT Prognostication Tool in US Patients With Breast Cancer.
Stabellini N; Cao L; Towe CW; Miller ME; Sousa-Santos AH; Amin AL; Montero AJ
J Natl Compr Canc Netw; 2023 Oct; 21(10):1011-1019.e6. PubMed ID: 37856198
[TBL] [Abstract][Full Text] [Related]
18. Association of Circulating Tumor Cell Status With Benefit of Radiotherapy and Survival in Early-Stage Breast Cancer.
Goodman CR; Seagle BL; Friedl TWP; Rack B; Lato K; Fink V; Cristofanilli M; Donnelly ED; Janni W; Shahabi S; Strauss JB
JAMA Oncol; 2018 Aug; 4(8):e180163. PubMed ID: 29800954
[TBL] [Abstract][Full Text] [Related]
19. Independent validation of the PREDICT breast cancer prognosis prediction tool in 45,789 patients using Scottish Cancer Registry data.
Gray E; Marti J; Brewster DH; Wyatt JC; Hall PS;
Br J Cancer; 2018 Oct; 119(7):808-814. PubMed ID: 30220705
[TBL] [Abstract][Full Text] [Related]
20. Survival analysis in patients with invasive lobular cancer and invasive ductal cancer according to hormone receptor expression status in the Korean population.
Kwon D; Ko BK; Jung SP; Kim HK; Kim EK; Jung YS; Youn HJ; Lee SB
PLoS One; 2022; 17(1):e0262709. PubMed ID: 35051228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]